Amicus Therapeutics, Inc. (FOLD) has a consensus analyst rating of Buy, based on 24 analysts covering the stock. Of those, 16 recommend buying, 7 recommend holding, and 1 recommend selling.
The analyst consensus price target for FOLD is $14.50, representing a +0.3% upside from the current price of $14.46. Price targets range from a low of $14.50 to a high of $14.50.
